Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study.

Saved in:
Bibliographic Details
Title: Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study.
Authors: Kovács J; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary.; Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary., Köllő Z; Department of Laboratory Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Karvaly BG; Department of Laboratory Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary., Obeidat M; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary., Nagy R; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary.; Heim Pál National Pediatric Institute, Budapest, Hungary.; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary., Hegyi P; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary.; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.; Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary., Teutsch B; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary.; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.; Department of Radiology, Medical Imaging Centre, Semmelweis University, Budapest, Hungary., Tuboly E; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary.; Wolfson Childhood Cancer Research Centre, Newcastle Centre for Cancer, Newcastle University, Newcastle Upon Tyne, UK., Garami M; Centre For Translational Medicine, Semmelweis University, Budapest, Hungary.; Pediatric Center, MTA Center of Excellence, Semmelweis University, Budapest, Hungary.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2026 Jul; Vol. 73 (7), pp. e70318. Date of Electronic Publication: 2026 Apr 20.
Publication Type: Journal Article
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1545-5017
DOI:10.1002/1545-5017.70318